Search results
Alison Lawton (born May 29, 1970) is a Canadian social venture philanthropist, social advocate, and business investor.
Alison Lawton is the founder and president of Mindset Venture Group, a company that invests in early-stage businesses and social ventures. She has a diverse portfolio of investments in technology, consumer, and real estate sectors, and is also involved in global health and social impact initiatives.
Alison Lawton most recently served as Kaleido’s Chief Executive Officer, President and as a member of the Board of Directors since August 2018, after initially joining the company as President and Chief Operating Officer in December 2017.
- Chair
- Magenta Therapeutics, Magenta Therapeutics
Alison Lawton is an executive leader with more than 30 years of biopharma experience, having most recently served as president and CEO of Kaleido Biosciences. Previously, she served as chief operating officer (COO) of Aura Biosciences and OvaScience.
Dec 17, 2020 · Lawton currently serves as independent director for X4 Pharmaceuticals and ProQR Therapeutics and has served on the Boards of Directors of Verastem, CoLucid until its acquisition by Eli Lilly, and Cubist Pharmaceuticals until its acquisition by Merck & Co.
Seasoned Biotech Executive with experience as CEO, Chair and independent director of…. · Experience: Dianthus Therapeutics, Inc. · Location: Lincoln · 500+ connections on LinkedIn. View ...
- Dianthus Therapeutics, Inc.
Jan 19, 2021 · Alison Lawton, a biopharma industry veteran with experience in drug development and commercialization, has been appointed to the Board of Directors of SwanBio Therapeutics, a gene therapy company. SwanBio is advancing AAV-based therapies for neurological conditions.
